Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allograft Rejection”

215 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 215 results

Not applicableEnded earlyNCT03780101
What this trial is testing

Pathology and Imaging in Kidney Allografts

Who this might be right for
Renal Transplant RejectionChronic Kidney DiseasesFibrosis
NHS Greater Glasgow and Clyde 29
Not applicableNot Yet RecruitingNCT07434869
What this trial is testing

Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD

Who this might be right for
Lung Transplant Failure and RejectionCLAD, Bronchiolitis ObliteransExtracorporeal Photopheresis
Brian Keller 25
Testing effectiveness (Phase 2)Ended earlyNCT00568477
What this trial is testing

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation

Who this might be right for
GraftingRenal TransplantationTransplantation, Kidney+1 more
Technical University of Munich 200
Not applicableLooking for participantsNCT06314230
What this trial is testing

Australian Genomics Of Chronic Allograft Dysfunction Study

Who this might be right for
Kidney Transplant RejectionKidney Transplant; Complications
Western Sydney Local Health District 500
Testing effectiveness (Phase 2)Study completedNCT05983770
What this trial is testing

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Eledon Pharmaceuticals 127
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Post-approval studies (Phase 4)Study completedNCT01239472
What this trial is testing

Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant

Who this might be right for
Renal Transplant RejectionImmunosuppression
Andre Barreto Pereira 30
Testing effectiveness (Phase 2)WithdrawnNCT00261547
What this trial is testing

Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients

Who this might be right for
Chronic RejectionKidney Insufficiency
Massachusetts General Hospital
Not applicableStudy completedNCT02077764
What this trial is testing

The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients.

Who this might be right for
Heart Transplant Recipients
Aarhus University Hospital Skejby 65
Not applicableNot Yet RecruitingNCT05890430
What this trial is testing

Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation

Who this might be right for
Kidney TransplantationKidney Allograft BiopsyHumoral Rejection+1 more
University Hospital, Strasbourg, France 570
Not applicableStudy completedNCT03582436
What this trial is testing

Rejection Diagnosis in Kidney Transplants Patients

Who this might be right for
Kidney TransplantationTransplant RejectionGraft Survival
Assistance Publique - Hôpitaux de Paris 824
Not applicableStudy completedNCT00056784
What this trial is testing

The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 134
Not applicableEnded earlyNCT03937765
What this trial is testing

The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites

Who this might be right for
Skin Graft (Allograft) RejectionSkin Graft ComplicationsSkin Graft Detachment+1 more
University of Arizona 25
Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Not applicableStudy completedNCT05747274
What this trial is testing

SRDK0921_ Analytical Performance Study

Who this might be right for
Kidney Transplant Rejection
BioMAdvanced Diagnostics 439
Large-scale testing (Phase 3)Looking for participantsNCT04877288
What this trial is testing

Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Who this might be right for
Renal Allograft Recipients
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Study completedNCT00089947
What this trial is testing

Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

Who this might be right for
Renal TransplantationGraft Rejection
Genzyme, a Sanofi Company 150
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Not applicableLooking for participantsNCT01531257
What this trial is testing

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Who this might be right for
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University 1,000
Post-approval studies (Phase 4)Study completedNCT01649427
What this trial is testing

Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

Who this might be right for
Pharmacokinetics Study in de Novo Kidney Transplantation
Novartis Pharmaceuticals 73
Load More Results